| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.25 | 0.1 |